Research Article
Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension
Table 5
Predictive values of NLR for 3-month all-cause mortality.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Model 1, adjustment for age, sex, and BMI. Model 2, adjustment for Model 1 plus HT, DM, CHD, AF, BNP, and eGFR. Model 3, adjustment for Model 2 plus LAVI, LVEF, LVMI, E/e′, and peak AV velocity. NLR, neutrophil-to-lymphocyte ratio; BMI, body mass index; HT, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; AF, atrial fibrillation; BNP, B-type natriuretic peptide; eGFR, estimated glomerular filtration rate; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; E/e′, early diastolic transmitral flow velocity/lateral mitral annular myocardial velocity; AV, aortic valve. |